These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22434036)

  • 1. Use of interferon-γ enzyme-linked immunospot assay to characterize novel T-cell epitopes of human papillomavirus.
    Wang X; Greenfield WW; Coleman HN; James LE; Nakagawa M
    J Vis Exp; 2012 Mar; (61):. PubMed ID: 22434036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memory T cells specific for novel human papillomavirus type 16 (HPV16) E6 epitopes in women whose HPV16 infection has become undetectable.
    Wang X; Moscicki AB; Tsang L; Brockman A; Nakagawa M
    Clin Vaccine Immunol; 2008 Jun; 15(6):937-45. PubMed ID: 18448624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell response to human papillomavirus type 52 L1, E6, and E7 peptides in women with transient infection, cervical intraepithelial neoplasia, and invasive cancer.
    Chan PK; Liu SJ; Cheung JL; Cheung TH; Yeo W; Chong P; Man S
    J Med Virol; 2011 Jun; 83(6):1023-30. PubMed ID: 21503915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of a cervical cancer derived tumor cell line by a human papillomavirus type 16 E6 52-61-specific CD8 T cell clone.
    Kim KH; Dishongh R; Santin AD; Cannon MJ; Bellone S; Nakagawa M
    Cancer Immun; 2006 Jun; 6():9. PubMed ID: 16808432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an HLA-A24-restricted cytotoxic T lymphocyte epitope from human papillomavirus type-16 E6: the combined effects of bortezomib and interferon-gamma on the presentation of a cryptic epitope.
    Morishima S; Akatsuka Y; Nawa A; Kondo E; Kiyono T; Torikai H; Nakanishi T; Ito Y; Tsujimura K; Iwata K; Ito K; Kodera Y; Morishima Y; Kuzushima K; Takahashi T
    Int J Cancer; 2007 Feb; 120(3):594-604. PubMed ID: 17096336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an interferon-gamma ELISPOT assay to detect human T cell responses to HSV-2.
    Posavad CM; Magaret AS; Zhao L; Mueller DE; Wald A; Corey L
    Vaccine; 2011 Sep; 29(40):7058-66. PubMed ID: 21801778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel CD4 T-cell epitope described from one of the cervical cancer patients vaccinated with HPV 16 or 18 E7-pulsed dendritic cells.
    Wang X; Santin AD; Bellone S; Gupta S; Nakagawa M
    Cancer Immunol Immunother; 2009 Feb; 58(2):301-8. PubMed ID: 18446336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers.
    Riemer AB; Keskin DB; Zhang G; Handley M; Anderson KS; Brusic V; Reinhold B; Reinherz EL
    J Biol Chem; 2010 Sep; 285(38):29608-22. PubMed ID: 20615877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus 16-specific T cell responses in classic HPV-related vulvar intra-epithelial neoplasia. Determination of strongly immunogenic regions from E6 and E7 proteins.
    Bourgault Villada I; Moyal Barracco M; Berville S; Bafounta ML; Longvert C; Prémel V; Villefroy P; Jullian E; Clerici T; Paniel B; Maillère B; Choppin J; Guillet JG
    Clin Exp Immunol; 2010 Jan; 159(1):45-56. PubMed ID: 19843089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of T cell epitopes by the use of rapidly generated mRNA fragments.
    Britten CM; Meyer RG; Graf C; Huber C; Wölfel T
    J Immunol Methods; 2005 Apr; 299(1-2):165-75. PubMed ID: 15914199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.
    Hamrouni S; Bras-Gonçalves R; Kidar A; Aoun K; Chamakh-Ayari R; Petitdidier E; Messaoudi Y; Pagniez J; Lemesre JL; Meddeb-Garnaoui A
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008093. PubMed ID: 32176691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of peptide-specific and gamma interferon-productive T cells in patients with active and convalescent tuberculosis using an enzyme-linked immunosorbent spot assay.
    Yang FF; Tu ZQ; Fang YM; Li Y; Peng Y; Dong T; Wang C; Lin SX; Zhan NY; Ma ZM; Feng YZ; Tan SY; Lai XM
    Clin Vaccine Immunol; 2012 Mar; 19(3):401-10. PubMed ID: 22237892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of vaccine candidate peptides in the NcSRS2 surface protein of Neospora caninum by using CD4+ cytotoxic T lymphocytes and gamma interferon-secreting T lymphocytes of infected holstein cattle.
    Staska LM; Davies CJ; Brown WC; McGuire TC; Suarez CE; Park JY; Mathison BA; Abbott JR; Baszler TV
    Infect Immun; 2005 Mar; 73(3):1321-9. PubMed ID: 15731029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peptide mapping of H-2d restricted T-cell epitope against six antigens of HIV-1 subtype B'/C by ELISPOT assay].
    Qi XR; Gao YY; Lu RJ; Deng Y; Meng X; Tan WJ; Ruan L
    Bing Du Xue Bao; 2011 Jan; 27(1):34-43. PubMed ID: 21462504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer.
    Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Zhan D; Pecorelli S; Parham GP; Cannon MJ
    J Virol; 1999 Jul; 73(7):5402-10. PubMed ID: 10364287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of CD4(+)- and CD8(+)-T-cell responses to human papillomavirus type 1 antigens expressed at various stages of the virus life cycle by using an enzyme-linked immunospot assay of gamma interferon release.
    Steele JC; Roberts S; Rookes SM; Gallimore PH
    J Virol; 2002 Jun; 76(12):6027-36. PubMed ID: 12021335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a major histocompatibility complex class I-restricted T-cell epitope in the tumour-associated antigen, 5T4.
    Redchenko I; Harrop R; Ryan MG; Hawkins RE; Carroll MW
    Immunology; 2006 May; 118(1):50-7. PubMed ID: 16630022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identificaiton of Novel Immunogenic Human Papillomavirus Type 16 E7-Specific Epitopes Restricted to HLA-A*33;03 for Cervical Cancer Immunotherapy.
    Kim S; Chung HW; Kong HY; Lim JB
    Yonsei Med J; 2017 Jan; 58(1):43-50. PubMed ID: 27873494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immune responses to human papillomavirus 16 E6 and E7 antigens as measured by interferon gamma enzyme-linked immunospot in women with cleared or persistent human papillomavirus infection.
    Farhat S; Nakagawa M; Moscicki AB
    Int J Gynecol Cancer; 2009 May; 19(4):508-12. PubMed ID: 19509544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.